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Abstract: An efficient synthesis of methyl 4-[(1-oxopropyl)phenylamino]piperidine-4-car-
boxylate (7) has been developed, starting from 1-benzylpiperidin-4-one (1). The compound
is a key intermediate in the synthesis of new generation, highly active narcotic analgesics,
such as remifintanil, as well as the novel classes of fentanyl analogues. An optimized
Strecker-type condensation of piperidone 1 with aniline and HCN yielded the anilino-nitrile
2 (90 %) which, upon selective hydrolysis with conc. H2SO4, gave the anilino-amide 3. Af-
ter vigorous basic hydrolysis of 3, followed by acidification and successive treatment with
SOCl2 and MeOH, the anilino-ester 5 was obtained (40–45 %, in 3 steps). N-Acylation of 5
with propionyl chloride yielded the anilido-ester 6 (70–80 %). In the final step, the catalytic
N-debenzylation of 6 was examined under various conditions and optimized to yield 7 in
near quantitative yields.
Keywords: optimized Strecker reaction, functionalized piperidines, fentanyl-type central an-
algesics.
INTRODUCTION
Opioid agonists play a very significant role in contemporary clinical practice, both in short
term and long term alleviation of pain, as well as in various fields of biomedical research.1–3
Opioid antagonists too, have been widely used experimentally and to a limited extent clinically
(mainly to treat opioid overdose). Among the three types of agonists, relatively specific for , 
and  receptors respectively,  agonists are the most significant therapeutically. These include
structurally highly diverse compounds such as morphine,4 meperidine,4 methadone,4 fenta-
nyl,4 etonitazene,4 various peptides (CRF, dynorphin, endorphins, nociceptin)4 and others.
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4-Anilido-piperidines5 (fentanyl analogues) represent a particular class of  agonists, character-
ized by very high analgesic potency, relatively short duration of action and good overall safety
margin during surgical anesthesia. The clinically most useful drugs in this group, i.e., fentanyl,4
remifentanil,4 sufentanil4 and alfentanil,4 are depicted in Scheme 1.
Avery large number of fentanyl analogues have been synthesized in the past 30 years,
with the aim of establishing a SAR (structure-activity relationship), to probe the receptor
structure and to produce novel, clinically useful drugs with better pharmacological profile.
The latter includes higher potency, higher receptor selectivity, less side effects such as re-
spiratory depression and lower addiction potential.
Initially, fentanyl and its analogues were used only in surgical anesthesia and to treat
postoperative pain. In recent years, however, it also became a useful drug in controlling se-
vere chronic pain, through transdermal patches (Duragesic®).6 As fentanyl does not pene-
trate human skin readily, it would be useful, inter alia, to develop novel derivatives with
better skin resorption.
In general, although the contemporary narcotic analgesics are highly useful and potent
(some are more than 1000 times more potent than morphine), they still suffer from diverse
and serious drawbacks. Hence, there is a constant need for a next generation of these drugs,
with more acceptable pharmacological profiles.
RESULTS AND DISCUSSION
As part of our efforts to synthesize various novel derivatives of remifentanil, su-
fentanil and alfentanil, a substantially improved and modified synthesis of methyl 4-[(1-oxo-
propyl)phenylamino]piperidine-4-carboxylate (7) has been developed. Compound 7 and
its precursor 5 are known5e–5g to be key intermediates in the synthesis of substituted
fentanyl derivatives possessing groups such as 4-methoxycarbonyl, 4-methoxymethyl and
others as outlined in Scheme 2. It also provides access to numerous other 4,4-disubstituted
piperidine derivatives. The published syntheses of 7 suffer from low overall yields, tedious
intermediate isolation and/or impure final product, as was evidenced in this research.
The synthesis presented herein is accomplished in 7 steps, starting from 1-benzyl
piperidine-4-one (1), Scheme 3.
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Scheme 1.
Piperidone 1 was condensed with aniline and HCN to yield the Strecker type ani-
lino-nitrile 2. Although this reaction has been the subject of numerous papers and patents, the
yields and/or purity of the products, including 2, have been quite variable and generally below
50 %. In this research the reaction conditions were optimized with respect to the solvent, reac-
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Scheme 2.
Scheme 3.
tion temperature, molar ratio of the reactants and the acid catalyst. Initially, simple model ke-
tones, such as cyclohexanone and 4-phenylbutan-2-one, were used for a rough estimate of the
reaction parameters. This was followed by a detailed optimization on piperidone 1, and
piperidone 1a. The optimal molar proportion of the reagents was found to be 4 eq. of KCN and
4 eq. of aniline per 1 eq. of ketone, with various solvents and acid catalysts. Lower proportions
diminished the yields while higher proportions result in no further improvements.
Of the solvents tested (MeOH, EtOH, i-PrOH, pure AcOH, acetonitrile, CH2Cl2), the
mixture CH2Cl2/AcOH (1:1) gave optimal results. The role of the CH2Cl2 is to dissolve
the liberated HCN during the addition of AcOH at –5 to 0 ºC.
Although Strecker-type condensations are usually performed at 0–20 ºC, we found
that subsequent heating at 45–50 ºC for 12–36 h was necessary to achieve nearly quantita-
tive yields, possibly according to Scheme 4. A slight positive pressure of HCN was main-
tained in the apparatus using a mercury filled bubbler. In general, the amino-ketones
(piperidones) were found to be much less reactive then the model ketones.
Although the reaction mechanism was not investigated in this research, it is known7
that it involves cyanide ion addition to protonated imines, Scheme 4. Cyanohydrins are un-
likely intermediates as they do not form carbocations readily. This is corroborated by the
fact that sugar cyanohydrins (as well as other cyanohydrins) are hydrolyzed to -hydroxy
acids in dil. HCl (Kiliani-Fischer synthesis) without dehydration or chlorine substitu-
tion.7–14 Similarly, acid-catalyzed esterification of -hydroxy acids is easily accomplished
with no dehydration.15 To effect dehydration of cyanohydrins or -hydroxy acids, likely
via formation of carbocation intermediates, much more vigorous conditions are required.
These include heating with SOCl216 or H2SO4.17 However, extensive decomposition was
observed in the latter instance.
Since the cyanohydrins are actually formed in the course of the Strecker synthesis (as
evidenced by tlc and instrumental methods), apparently the reverse reaction, HCN elimi-
nation, takes place upon heating, enabling the complete conversion of carbonyl com-
pounds to amino-nitriles.
Among the examined acid catalysts, it was found that acetic acid, used as co-solvent
with CH2Cl2, proved to be superior in terms of yields and purity. Other catalysts, e.g., pure
AcOH, TFA, HCl (aq.) TsOH, MsOH and AcOH/ZnCl2, gave lower yields.
The procedure is equally applicable to 1-phenethyl-4-piperidone (1a) (90 % yield of
the anilino-nitrile 2a), however it fails completely with 3-methyl-1-phenethyl-piperi-
din-4-one, apparently due to steric factors. Some of the results are summarized in Table I.
In should be pointed out that the reaction protocol presented herein is applicable to a
variety of ketones and also to some aliphatic amines such as benzylamine.
Numerous attempts to convert the anilino-nitrile 2 directly to the anilino-ester 5 (via a
Pinner-type reaction18,19) failed. Thus reactions with MeOH/HCl, MeOH/HBr,
MeOH/MsOH and MeOH/H2SO4 under various conditions, led exclusively to the starting
piperidone 1, due to the retro-Strecker process. The conversion was finally effected by
modification of a known, three step procedure.
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The anilino-nitrile 2 was selectively hydrolyzed to the corresponding anilino-amide 3
by dissolving in conc. H2SO4 and stirring for 24 h at 20 ºC. As the formed dihydro-
gensulphate salt of 3 is insoluble in the reaction medium, hydrolysis does not proceed further.
The precipitated salt was first converted to the free base 3, then subjected to vigorous basic
hydrolysis (KOH, 1,2-propylene glycol, 200 ºC, 12 h, cat. 18-C-6) to yield the ani-
lino-carboxylic acid 4 as the potassium salt. Various protocols to isolate this salt or the free
acid 4 were examined, resulting only in very low yields. The problem was circumvented by
acidification of the reaction mixture (conc. HCl, pH < 1), followed by solvent removal under
reduced pressure. The resulting crude, solid, dihydrochloride of 4 was then heated with ex-
cess SOCl2 in chlorobenzene (120 ºC, cat. DMF, 3–4 h) to form the acid chloride, followed
by in situ treatment with excess methanol (at 20 ºC). After solvent removal and dry flash
chromatography, the anilino-ester 5 was obtained in 40–45 % yield (for 3 steps).
TABLE I. Optimization of the Strecker-type condensation of piperidone 1
Aniline/mol % Solvent# Acid KCN/mol % t/ºC time / h Isolated yield/%
120 MeOH AcOH (2eq) 200 0–20 48 0–5
400 MeOH AcOH (10 eq) 400 0–20 48 20–30
400 CH2Cl2 AcOH (30–50 eq) 400 0–20 48 45–55
400 AcOH AcOH (50 eq) 400 0–20 48 45–55
400 AcOH AcOH (50 eq) 400 0–20 7 days
60
400 CH2Cl2 AcOH (30–50 eq) 400 0–50 48 85–95
# the use of molecular sieves 4A did not affect the yields substantially
The N-acylation of anilino-ester 5 was examined with various solvents and reagents.
As a result of steric hidrance and low nucleophilicity of the aromatic amino group, the re-
action is slow and often accompanied by decomposition. Various solvents and reagents
were tested, usually resulting in lower yields or side products. Thus, with propionyl chlo-
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Scheme 4.
ride in boiling CH2Cl2, the acylation practically did not proceed while in chlorobenzene
(100–120 ºC) it resulted in massive decomposition. Similarly, the addition of pyridine or
DMAP yielded numerous side products, while propionic anhydride at lower temperatures
(< 100 ºC) was an ineffective acylating agent. In the boiling anhydride, however, gross de-
composition occurred. Finally, acceptable yields and purity of the anilido-ester 6 were ob-
tained using propionyl chloride (3 eq.), in boiling dichloroethane (80 ºC, 4–5 h) with the
gradual addition of triethylamine (1 eq.). The product was isolated and recrystallized from
methanol as the monooxalate salt (70–80 % yield of the pure free base).
In the final step of the synthesis, catalytic debenzylation of the anilido-ester 6 was ex-
amined using a Parr hydrogenation apparatus and varying amounts of 10 % Pd/C as cata-
lyst. Initially, hydrogenolysis failed to proceed in the absence of acid. Thus, no appreciable
reaction was observed in methanol, ethanol or ethyl acetate at 20–50 ºC (10 % Pd/C, 4–5
atm H2, 2–12 h), possibly due to catalyst poisoning. Similarly, transfer hydrogenolysis with
ammonium formate (at atmospheric pressure) yielded only negligible amounts of the de-
sired product. The addition of acetic acid dramatically improved the yields and the reaction
rate, however the obtained anilido-ester 7 was substantially contaminated with side prod-
ucts. A number of solvent systems were examined as summarized in Table II. Optimal
yields, purity and reaction rate were achieved in a H2O/AcOH mixture (3:2), in the pres-
ence of 5 eq. of HCl. Apparently, the purity of the product is substantially improved at
low pH values, (< 1), in aqueous medium.
TABLE II. Optimization of the N-debenzylation procedure of the anilido-ester 6
Conditions: solvents; temp.; time;
pressure
Catalyst
10 % Pd-C/wt. %
Isolated yield / %
Purity (GC; TLC; 1H
NMR)/%
1
HCO2NH4; MeOH;
24 h; 20 ºC; 1 atm
100 10–15 –
2
H2·MeOH or EtOH or EtOAc;
5 h; 20–50 ºC; 4–5 atm
50–100 0
3
H2; MeOH/AcOH (99:1);
24 h; 20ºC; 3–4 atm
10 80–90 85
4
H2; (EtOH or
i-PrOH)/(AcOH(99:1);
24 h; 20 ºC; 3–4 atm
10 80–90 85–90
5.
H2; AcOH(glac.); 4–6 h;
20 ºC; 3–4 atm
10 > 90 90
6.
H2; AcOH /H2O (4:6);
 500 mol% HCl; 3–4 h;
20 ºC; 3–4 atm
10 » 95 96–98
All the synthesized compounds were fully characterized by instrumental methods,
Table III, and the purity confirmed by capillary GC and tlc. (The data are given in the ex-
perimental section).
In conclusion, an efficient and optimized procedure for the synthesis of 4-[(1-oxopro-
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pyl)phenylamino]piperidine-4-carboxylic acid methyl ester (7) has been developed. A
useful protocol for a Strecker-type synthesis has been disclosed which is applicable to
sterically unhindered ketones including piperidones. Finally, it was established that cata-
lytic N-debenzylation of tertiary amines proceeds rapidly, selectively and quantitatively in
aqueous medium, at pH <  1.
EXPERIMENTAL
All solvents and reagents used in the experiments were reagent grade and additionally purified and dried
as appropriate. Molecular sieves (4A) were activated at 350 ºC (12 h), transferred to a steel container while hot
and kept tightly closed. Methanol, i-PrOH, CH2Cl2 (CH2Cl)2, DMF, EtOAc, PhCl and hexane were dried
over 4A sieves and distilled prior to use. Triethylamine was distilled from KOH. Propylene glycol was dis-
tilled (water aspirator vacuum) and the first 10 % of the distillate discarded. Aniline was distilled from Zn/HCl
(water aspirator vaccum) and dried over 4A sieves. Acetic acid was fractionally distilled from KMnO4.
Thionyl chloride was distilled. Silica gel 60, ICN Pharmaceuticals, particle size 10–18 m was used for dry
flash chromatography. Other reagents were used as received.
The 1H-NMR and 13C-NMR spectra were recorded with a Varian Gemini spectrometer at 200 MHz and 50
MHz respectively, in CDCl3, relative to Me4Si. The IR spectra were recorded on a Perkin Elmer FTIR 1725X
spectrometer. The mass spectra were obtained on a Math Finnegan instrument, model 8230, using iso-butane for
chemical ionization. The gas chromatograms were recorded on a Varian 3400 instrument, using capillary columns
DB-1 and DB-5. The thin layer plates were coated with Merck silica gel 60, HF254, 0.25 mm thickness.
1-Benzyl-4-phenylaminopiperidine-4-carbonitrile (2)
WARNING: HCN is an extremely lethal and volatile liquid/gas (b.p. 25 ºC). The reaction must be
perfomed under a very efficient hood to prevent exposure to HCN. During the work-up procedure at least, it is
mandatory to wear a gas-mask fitted with an appropriate filter. The residual solution, containing KCN must be
slowly treated with a large excess of commercial sodium hypochlorite solution prior to disposal.
The apparatus consisted of a single necked, round bottomed flask (1L) equipped with a reflux con-
denser and pressure equalizing dropping funnel fitted atop the condenser. The funnel was capped with a rub-
ber septum connected via a needle and tubing to a mercury filled bubbler. The flask was charged with
piperidone 1 (0.10 mol; 18.9 g), aniline (0.40 mol; 37.2 g), solid KCN (0.40 mol; 26.0 g) and CH2Cl2 (200
mL). The mixture was cooled (5 ºC, ice-acetone bath) and stirred magnetically. The dropping funnel was
charged with AcOH (3.0 mol; 180 mL) which was added dropwise, over an 3 h period, to the heterogeneous
reaction mixture. The stirring was continued, and the mixture was heated (oil bath) at 45–50 ºC for 24 h. Some
HCN evolved through the bubbler. After cooling to 20ºC, the contents were poured (hood, gas-mask) onto
crushed ice (500 g), then partially neutralized (cold 25 % NaOH solution, 3.0 mol; 120 g). The neutralization
was completed with K2CO3 (40 % solution , 1.0 mol; 138 g) to pH10. The layers separated and the aqueous
layer was extracted with CH2Cl2 (2 x 300 mL). The combined organic layers were concentrated (rotatory
evaporator) and the liquid residue dissolved in i-PrOH (250 mL). After 48 h (at –10 ºC) the crystallized
anilino-nitrile 2 was isolated by filtration, washed with i-PrOH (2 X 50 mL cooled at –20 ºC) and dried under
reduced pressure. Yield: 26.2 g (90 %); white crystals. M.p. 105 ºC (lit.5e 105 ºC).
IR: 3405, 2954, 2227, 1602, 1511, 1459, 1319, 1283, 1267, 1174, 1158, 748, 698; 1H-NMR: 1.92 (td, J1
= 3.6, J2 = 10.8, 2H), 2.29–2.53 (m, 4H), 2.79–2.85 (m. 2H), 3.56 (s, benz. CH2), 3.64 (s, NH) 6.88–6.95 (m,
3HAr) 7.20–7.33 (m, 7HAr);
13C-NMR: 36.09, 49.27, 59.06, 62.58, 117.78, 120.93, 127.26, 128.96, 129.00,
129.31, 134.02, 138.00, 143.29; MS: 292 (M+1, 80), 265 (50), 264 (M – HCN, 100).
1-Phenethyl-4-phenylaminopiperidine-4-carbonitrile (2a)
Compound 2a was prepared by the same protocol as compound 2, utilizing 1-phenethylpiperidin-4-one
(1a) (20.3 g; 0.1 mol) and the same amounts of the other reagents and solvents. Yield: 28.1 g (92 %); white
crystals. M.p. 118–119 ºC (lit.5e 120 ºC).
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IR: 3375, 2964, 2235, 1605, 1527, 1499, 1346, 1324, 1106, 751, 704, 694; 1H-NMR: 1.93 (td, J1 = 3.0,
J2 = 13.2, 2H), 2.34–2.41 (m, 2H), 2.52 (td, J1 = 2.2, J2 = 13.0, 2H), 2.62–2.71 (m, 2H), 2.76–2.84 (m, 2H),
2.85–2.94 (m, 2H), 3.67 (s, NH), 6.85–7.0 (m, 3HAr), 7.15–7.38 (m, 7HAr);
13C-NMR: 33.66, 36.05, 49.28,
53.00, 59.86, 117.74, 120.58, 120.92, 126.13, 128.41, 128.64, 129.30, 139.99, 143.25; MS: 597 (2M + 1, 0.4),
306 (M+1, 71), 278 (M – HCN, 100).
1-Benzyl-4-phenylaminopiperidine-4-carboxylic acid amide (3)
The nitrile 2 (25.0 g, 86 mmol) was dissolved in conc. H2SO4 (250 mL) at 20 ºC, in a single necked
flask protected with a CaCl2 trap. The mixture was stirred magnetically for 24 h, then the precipitated
dihydrogensulphate salt of amide 3 was collected by filtration. The precipitate was dissolved in water (300
mL) and titrated with NaOH (25 % solution) to pH > 10. The separated free amide 3 was filtered off, washed
with water and air dried. Yield: 22.1 g (83 %). An analytical sample was prepared by recrystallizing from
i-PrOH. M.p. 167 ºC (lit.5e 167.5 ºC).
IR: 3445, 3355, 3058, 2959, 2810, 1678, 1605, 1519, 1499, 1473, 1443, 1365, 1342, 1326, 1308, 1266,
1196, 1185, 1169, 1154, 1113, 1063, 745, 734, 697; 1H-NMR: 1.93 (d, J = 11.8, 2H), 2.11 (t, J = 13.4, 2H),
2.34 (td, J1 = 2.6, J2 = 12.0, 2H), 2.73–2.79 (m, 2H), 3.50 (benz. CH2), 4.02 (NH), 5.30 (CONH2), 6.63 (dd, J1
= 0.8, J2 = 8.8, 2HAr). 6.81 (t, J = 7.2, 1HAr), 7.15–7.32 (m, 7HAr);
13C-NMR: 31.21, 48.65, 58.10, 62.85,
116.09, 119.15, 127.10, 128.23, 128.98, 129.14, 137.96, 143.67, 178.65; MS: 310; M+1 (100).
1-Benzyl-4-phenylaminopiperidine-4-carboxylic acid methyl ester (5)
A single necked flask equipped with a reflux condenser was charged with amide 3 (20.0 g, 65 mmol),
solid 85 % KOH (260 mmol, 17.0 g), 18-crown-6-ether (5-mmol, 1.3 g) and 1,2-propylene glycol (150 mL).
(Note: the ground glass joint must be protected by Teflon tape to prevent sticking). The mixture was stirred
magnetically and heated (oil or air bath) to reflux for 24 h, then cooled to room temperature. Conc. HCl (40
mL) was added dropwise, with stirring, to pH < 1 (indicator paper). The solvent was evaporated (rotatory
evaporator, oil bath, water aspirator) and the last traces removed with an oil pump. The solid residue, the
dihydrochloride of anilino-acid 4 mixed with KCl, was transferred to a flask fitted with a reflux condenser and
CaCl2 trap, suspended in chlorobenzene (150 mL), followed by the addition of SOCl2 (0.26 mol, 19.3 mL)
and DMF (1.0 mL, 14 mmol). The mixture was stirred magnetically and heated at reflux for 5 h (SO2 and HCl
evolution) whereupon the color changed from tan to dark brown. After cooling to room temperature, MeOH
(50 mL) was added slowly (vigorous gas evolution) and the stirring continued for 1 h. The heterogeneous
mixture was concentrated (rotatory evaporator, oil bath), then treated with K2CO3 (25 % solution) to pH > 10.
The mixture was extracted with toluene (3 X 100 mL), the combined extracts concentrated (rotatory evapora-
tor) and the residue purified by dry flash chromatography (hexane/EtOAc, gradient 100/0 to 70/30). The pale
yellow anilino-ester 5 was isolated as a viscous oil which crystallized upon standing. Yield: 8.6 g (41 %). M.p.
105 ºC (lit.5e 105 ºC).
IR: 3404, 3085, 3057, 3023, 2948, 2812, 1732, 1602, 1500, 1467, 1453, 1434, 1397, 1368, 1346, 1319,
1297, 1266, 1233, 1187, 1148, 1120, 1085, 1067, 1026, 1003, 746, 698. 1H-NMR: 1.98–2.06 (m, 2H), 2.24
(td, J1 = 3.4, J2 = 13, 2H), 2.40 (td, J1 = 2.6, J2 = 10, 2H), 2.65 (m, 2H), 3.50 (CH2 benz), 3.67 (CH3), 3.86
(NH), 6.56 (dd, J1 = 1.0, J2 = 6.8, 2HAr), 6.74 (t, J = 7.2, 1HAr), 7.10–7.32 (m, 7H);
13C-NMR:32.89, 48.85,
52.27, 58.19, 62.96, 115.23, 118.57, 127.05, 128.24, 129.11, 138.30, 144.93, 175.99; MS: 325 (M+1, 5),
324(M+, 13), 231 (57), 172 (85), 91 (100).
1-Benzyl-4-(N-phenylpropionylamino)piperidine-4-carboxylic acid methyl ester (6)
To a flask fitted with a reflux condenser, pressure equalizing funnel and CaCl2 trap were added
anilino-ester 5 (8.0 g, 25 mmol), dichloroethane (50 mL) and propionyl chloride (75 mmol, 6.5 mL). The
mixture was heated to reflux and stirred magnetically for 3 h, then Et3N (25 mmol, 3.5 mL) was added gradu-
ally (over 1 h) and the stirring continued for 2 h. The mixture was cooled to 20 ºC, methanol (5 mL) was added
and, after 1 h, the contents were poured into a 25 % K2CO3 solution (50 mL). The layers were separated and
the aqueous layer was extracted with CH2Cl2 (50 mL). The combined organic layers were dried (sieves 4A),
filtered and concentrated. The residual oil was dissolved in i-PrOH (25 mL) and added gradually, with stir-
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ring, to a solution of anh. oxalic acid (25 mmol, 2.25 g) in i-PrOH (25 mL). The solution was cooled (–20 ºC,
12 h), the precipitated oxalate salt collected by filtration and recrystallized from i-PrOH (50 mL). The free
base was liberated by adding the solid oxalate salt into a 25 % K2CO3 solution (50 mL), extracted (2  50 mL
CH2Cl2), dried (sieves 4A) and concentrated to afford 6. Yield: 7.3 g (77 %) as a pale yellow oil.
IR: 3061, 3028, 2975, 2939, 2850, 1742, 1657, 1595, 1492, 1451, 1384, 1355, 1297, 1256, 1216, 1191,
1128, 1095, 1067, 742, 707; 1H-NMR: 0.95 (J = 7.4, CH3), 1.63 (td, Jd = 4.2, Jt = 13.0, 2H), 1.88 (q, J = 7.6,
CH2), 2.26 (d, J = 13.0, 2H), 2.42 (dd, J1 = 2.2, J2 = 11.4, 2H), 2.56–2.62 (m, 2H), 3.43 (s, benz. CH2), 3.78 (s,
CH3), 7.13–7.43 (m, 10HAr);
13C-NMR: 8.94, 28.84, 33.34, 49.58, 51.82, 62.62, 62.74, 125.12, 126.76, 127.96,
128.03, 128.45, 128.87, 129.11, 130.49, 138.14, 139.28, 173.88; MS: 381 (M+1, 100), 438 (M+58, 10).
4-[(1-oxopropyl)phenylamino]piperidine-4-carboxylic acid methyl ester (7)
Anilido-ester 6 (5.0 g, 13 mmol) was dissolved in H2O/AcOH mixture (6:4, 50 mL) followed by the ad-
dition of conc. HCl (5.6 mL) and 10 % Pd/C (0.3 g). The mixture was transferred to a hydrogenation flask and
fitted into a Parr hydrogenation apparatus. After hydrogen purging (3 times), shaking was continued for 4–5 h
(20 ºC, 4 atm hydrogen pressure) whereupon a minimal drop in the pressure was observed. The reaction
mixture was filtered, poured onto crashed ice (100 g) and titrated with 20 % NaOH solution to pH10 (indica-
tor paper). The alternative workup involves concentration of the reaction mixture (rotatory evaporator) fol-
lowed by neutralization (20 % NaOH solution to pH10). After extraction with CH2Cl2 (3  50 mL), the
combined extracts were dried (anh. K2CO3), fitered and concentrated to afford pure anilido-ester 7 as a single
product. Yield: 3.6 g (95 %); pale yellow oil.
IR: 3313, 3061, 2973, 2941, 2877, 1740, 1660, 1595, 1491, 1451, 1379, 1353, 1325, 1296, 1254, 1220,
1188, 1138, 1103, 1070, 999, 961, 757, 731, 708; 1H-NMR: 0.96 (t, J = 7.6, CH3), 1.41–1.56 (m, 2H), 1.86 (t,
J = 7.4, CH2), 1.96 (NH), 2.23–2.29 (m, 2H), 2.84 (dt, Jd = 12.2, Jt = 4.6, 2H), 2.97 (td, Jt = 13.0, Jd = 2.6, 2H),
3.81 (s, CH3), 7.19–7.48 (m, 5HAr);
13C-NMR: 9.07, 28.99, 34.40, 42.77, 52.06, 63.07, 128.65, 129.29,
130.58, 139.32, 173.89, 174.08; MS: 291 (M+1, 100), 348 (M+58, 15).
I Z V O D
OPTIMIZOVANA SINTEZA ZNA^AJNOG FARMACEUTSKOG
INTERMEDIJERA METIL
4-[(1-OKSOPROPIL)FENILAMINO]PIPERIDIN-4-KARBOKSILATA
V. D. KIRICOJEVI]a, M. D. IVANOVI]a, I. V. MI]OVI]b,+ J. B. \OR\EVI]c, G. M. ROGLI]b i
Q. DO[EN-MI]OVI]a
aIHTM-Centar za hemiju, Wego{eva 12, Beograd, bHemijski fakultet, Univerzitet u Beogradu, Studentski
trg 12.16, Beograd, cPoqoprivredni fakultet, Univerzitet u Beogradu, Nemawina 66, Beograd – Zemun
U ovom radu razvijena je efikasna sintezametil 4-(fenil-propionil-amino)-piperi-
din-4-karboksilata (7), prolaze}i od 1-benzil piperidin-4-on-1 (1). Jediwewe 7 je kqu~ni
intermedijer u sintezi nove generacije visoko aktivnih narkoti~kih analgetika, kao {to je
remifentanil a tako|e i novih klasa analoga fentanyla. U optimizovanoj Strecker-ovoj
kondenzaciji priperidona 1 sa anilinom i HCN, dobijen je anilino-nitril 2 (» 90 % prinos)
~ijom je selektivnom hidrolizom pomo}u konc. H2SO4 postao anilino-amid 3. Intenzivnom
baznom hidrolizom ovog intermedijera, zaki{eqavawem a zatim sukcesivno reakcijom sa
SOCl2 i MeOH, sintetisan je anilino-estar 5 (40–45 % prinos u 3 faze). N-acelovawem
anilino-estra 5 sa propionil hloridom postao je anilido-estar 6 (70–80 % prinos). U
posledwom fazi sinteze izvr{ena je optimizacija kataliti~kog N-debenzilovawa ani-
lido-estra 6 do finalnog proizvoda 7, u pribli`no kvantitativnom prinosu.
(Primeqeno 16. maja, revidirano 26. avgusta 2002)
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